Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2021 and 2022.
-
Tight liquidity NBB
Cash and receivables cover 22 % of short-term debt in 2022; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2021.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2022
MITHRA PHARMACEUTICALS CDMO from Liège, company number BE0534912933, closed financial year 2022 with a result of € -14.6 million after tax. For that financial year MITHRA PHARMACEUTICALS CDMO recorded revenue of € 26.7 million and equity of € -14.6 million. Compared with financial year 2021, the result moved from € -2.1 million to € -14.6 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2023.
€ -14.6 million
▼ € 15 million vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -14.6 million
▼ 585 % more loss than in 2021
Profit after tax over the fiscal year.
€ 515,655
▼ 81% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -19.7 million.
People and assets in 2022
168.7
▲ 11.7 vs 2021
Average over the fiscal year, from the social balance sheet.
€ 13.9 million
▲ 24% vs 2021
€ 82,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 65 million
▼ 7% vs 2021
Of which on lease € 64.9 million.
Debts at end 2022
€ 54.7 million
▼ 10% vs 2021
€ 5.9 million is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 5.3 million
▲ 17% vs 2021
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 112 days on average.
€ 2.8 million
▲ 259% vs 2021
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|
| Revenue | € 33,743,966 | € 26,744,702 | ▼ 21% |
| Profit after taxes | € -2,130,815 | € -14,592,300 | ▼ € 12.5 million |
| Equity | € 349,781 | € -14,624,694 | ▼ € 15 million |
| Total debts | € 100,264,760 | € 101,047,304 | ▲ 1% |
| Cash | € 2,773,446 | € 515,655 | ▼ 81% |
| Land & buildings | € 1,455,879 | € 2,417,955 | ▲ 66% |
| Retained profit | € -5,072,444 | € -19,664,744 | ▼ € 14.6 million |
| Bank debt | € 60,692,426 | € 54,656,310 | ▼ 10% |
| Balance sheet total | € 100,614,541 | € 86,422,610 | ▼ 14% |
| Employees (FTE) | 157 | 168.7 | ▲ 11.7 |
Key figures of MITHRA PHARMACEUTICALS CDMO, fiscal years 2021 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to MITHRA PHARMACEUTICALS CDMO?
What happened at MITHRA PHARMACEUTICALS CDMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
MITHRA PHARMACEUTICALS CDMO is active according to the CBE. Legal situation: Opening faillissement.
- David Horn Solomon stepped down as director. NBB
- ALIUS MODI srl stepped down as director. NBB
- New annual accounts for financial year 2022: loss of € 14.6 million. Source: NBB ↗
- David Horn Solomon became a director. NBB
- VAN ROMPAY MANAGEMENT BV stepped down as director. NBB
- ALIUS MODI srl became a director. NBB
- YIMA SRL stepped down as director. NBB
- VAN ROMPAY MANAGEMENT BV became a director. NBB
In short
From € 2.1 million loss in 2021 to € 14.6 million loss in 2022.
Paid € 22,990 in corporate taxes since 2021.
Pays suppliers within 112 days on average.
A new publication or filing at MITHRA PHARMACEUTICALS CDMO? We notify you, reason included.
Follow MITHRA PHARMACEUTICALS CDMODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2022 annual accounts
David Horn Solomon
Managing director
since 2023 · until 2025
Managing director · represented by LEON VAN ROMPAY
since 2021 · until 2023
since 2022 · until 2025
Director · represented by François FORNIERI
Also active at: LE BOCHOLTZ, VITAMINES EVENTS, GUSTA SPRL, ARDENTIA IMMO, IMMO LIEGE PERRON, VIAE, EOLE RACING EVENTS
since 2019 · until 2022
Establishments
Establishment units
Physical locations of this company
Rue Saint-Georges 5
4000 Liège
Rue de l'Expansion 57
4400 Flémalle
Active since 15 February 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Domain
Domain
mithra.com
Registered
1998-07-08
Registrar
eNom, LLC
Expires
2026-05-18
Website info
Features
Security
Network
Details
- Company number
- 0534.912.933
- VAT number
- BE 0534.912.933
- Registered office
- Rue Saint-Georges 5, 4000 Liège
- Names & denominations
- MITHRA PHARMACEUTICALS CDMO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 4 June 2013
- Peppol
- Not registered
- Contact
- mithra.com
- Activities · NACE
Vervaardiging van geneesmiddelen